594 related articles for article (PubMed ID: 12734665)
21. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
[TBL] [Abstract][Full Text] [Related]
22. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
Feng S; Huang Y; Chen Z
Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
[TBL] [Abstract][Full Text] [Related]
23. Claudin-5 expression in in vitro models of the blood-brain barrier.
Cooper I; Cohen-Kashi-Malina K; Teichberg VI
Methods Mol Biol; 2011; 762():347-54. PubMed ID: 21717369
[TBL] [Abstract][Full Text] [Related]
24. Endothelial α6β4 integrin protects during experimental autoimmune encephalomyelitis-induced neuroinflammation by maintaining vascular integrity and tight junction protein expression.
Welser JV; Halder SK; Kant R; Boroujerdi A; Milner R
J Neuroinflammation; 2017 Nov; 14(1):217. PubMed ID: 29121970
[TBL] [Abstract][Full Text] [Related]
25. Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis.
Errede M; Girolamo F; Ferrara G; Strippoli M; Morando S; Boldrin V; Rizzi M; Uccelli A; Perris R; Bendotti C; Salmona M; Roncali L; Virgintino D
J Neuropathol Exp Neurol; 2012 Oct; 71(10):840-54. PubMed ID: 23001217
[TBL] [Abstract][Full Text] [Related]
26. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice.
Furuse M; Hata M; Furuse K; Yoshida Y; Haratake A; Sugitani Y; Noda T; Kubo A; Tsukita S
J Cell Biol; 2002 Mar; 156(6):1099-111. PubMed ID: 11889141
[TBL] [Abstract][Full Text] [Related]
27. Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy.
Carrano A; Hoozemans JJ; van der Vies SM; van Horssen J; de Vries HE; Rozemuller AJ
Neurodegener Dis; 2012; 10(1-4):329-31. PubMed ID: 22301467
[TBL] [Abstract][Full Text] [Related]
28. Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness.
Cohen-Kashi Malina K; Cooper I; Teichberg VI
Brain Res; 2009 Aug; 1284():12-21. PubMed ID: 19501061
[TBL] [Abstract][Full Text] [Related]
29. Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact.
Wolburg H; Wolburg-Buchholz K; Engelhardt B
Acta Neuropathol; 2005 Feb; 109(2):181-90. PubMed ID: 15549331
[TBL] [Abstract][Full Text] [Related]
30. Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis.
Peltonen S; Riehokainen J; Pummi K; Peltonen J
Br J Dermatol; 2007 Mar; 156(3):466-72. PubMed ID: 17300235
[TBL] [Abstract][Full Text] [Related]
31. Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
Bénardais K; Pul R; Singh V; Skripuletz T; Lee DH; Linker RA; Gudi V; Stangel M
Neurosci Lett; 2013 Oct; 555():165-70. PubMed ID: 24076006
[TBL] [Abstract][Full Text] [Related]
32. The protective effects of bioactive (RS)-glucoraphanin on the permeability of the mice blood-brain barrier following experimental autoimmune encephalomyelitis.
Giacoppo S; Galuppo M; Iori R; De Nicola GR; Bramanti P; Mazzon E
Eur Rev Med Pharmacol Sci; 2014; 18(2):194-204. PubMed ID: 24488908
[TBL] [Abstract][Full Text] [Related]
33. Effect of RNA interference of tight junction-related molecules on intercellular barrier function in cultured human keratinocytes.
Yamamoto T; Saeki Y; Kurasawa M; Kuroda S; Arase S; Sasaki H
Arch Dermatol Res; 2008 Oct; 300(9):517-24. PubMed ID: 18560860
[TBL] [Abstract][Full Text] [Related]
34. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
35. Formation of tight junction strands by expression of claudin-1 mutants in their ZO-1 binding site in MDCK cells.
Kobayashi J; Inai T; Shibata Y
Histochem Cell Biol; 2002 Jan; 117(1):29-39. PubMed ID: 11819095
[TBL] [Abstract][Full Text] [Related]
36. Protein components of the blood-brain barrier (BBB) in the mediobasal hypothalamus.
Norsted E; Gömüç B; Meister B
J Chem Neuroanat; 2008 Oct; 36(2):107-21. PubMed ID: 18602987
[TBL] [Abstract][Full Text] [Related]
37. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability.
Stamatovic SM; Shakui P; Keep RF; Moore BB; Kunkel SL; Van Rooijen N; Andjelkovic AV
J Cereb Blood Flow Metab; 2005 May; 25(5):593-606. PubMed ID: 15689955
[TBL] [Abstract][Full Text] [Related]
38. Claudin-11 expression and localisation is regulated by androgens in rat Sertoli cells in vitro.
Kaitu'u-Lino TJ; Sluka P; Foo CF; Stanton PG
Reproduction; 2007 Jun; 133(6):1169-79. PubMed ID: 17636171
[TBL] [Abstract][Full Text] [Related]
39. Tight junctions in brain barriers during central nervous system inflammation.
Coisne C; Engelhardt B
Antioxid Redox Signal; 2011 Sep; 15(5):1285-303. PubMed ID: 21338320
[TBL] [Abstract][Full Text] [Related]
40. Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.
Girolamo F; Errede M; Longo G; Annese T; Alias C; Ferrara G; Morando S; Trojano M; Kerlero de Rosbo N; Uccelli A; Virgintino D
PLoS One; 2019; 14(3):e0213508. PubMed ID: 30870435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
